Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > Trading Halted

<< Previous

Bullboard Posts

Next >>

Comment by ssdasmmon Apr 28, 2021 5:10pm

125 Views

Post# 33087539

RE:RE:RE:RE:Trading Halted

Like Cameron said on the Jan 4 interview (45 Minute mark) they have enough money to get through daily bussiness, caps and HPV launch and VTM rollout and expansion, but what they are not capitalized for are ongoing discussions like providing the expansion for VTM (2 X current capacity alloted for Ontario) for other provinces or to provide 10x current monthly capacity for CAPS....''High classs problems to have''......Well worth a listen to again. This Financing is for a reason and we should find out in very short order. Micro-cap buisiness no more......

<< Previous

Bullboard Posts

Next >>

A potential breakthrough in spinal cord and optic nerve injury treatment